ライフサイエンスコーパス: PEF

1 PEF and spirometry were recorded in 186 cases and 160 co

2 PEF caused a decrease in available free amino groups of

3 PEF efficiently reduced fluorescent AGE formation in bre

4 PEF is a valid measure of health status in older persons

5 PEF processing at approximately 690kJ/kg and pH 4 increa

6 PEF treatments above 0.5kV/cm caused tubers to soften, b

7 PEF treatments did not affect the final temperatures of

8 PEF treatments did not affect the pH or total acidity of

9 PEF treatments were applied at 20 or 26 kV cm(-1) for 34

10 PEF used as food ingredient allows obtaining a tasty foo

11 PEF, symptoms, and bronchodilator use over the 14 d befo

12 PEFs are postulated to be caused by (i) plus-end-directe

13 PEFs are proposed to facilitate congression by pushing c

14 A PEF treatment of 3.4 kV/cm and 105 mus (35 pulses of 3 m

15 The application of a PEF treatment (2 kV/cm; 11.25 kJ/kg) to the olive paste

16 After PEF treatment at the electric field strength between 0.2

17 elerating uptake beginning immediately after PEF exposure and the other by high-level, accelerating f

18 enaturation was approximately 13% less after PEF treatments compared with the thermal treatments.

19 nifested sometimes hundreds of seconds after PEF exposure.

20 120 ml (6.1%), FVC within 150 ml (5.3%), and PEF within 0.80 L (12%).

21 heaosortase B in two of the same archaea and PEF-CTERM/archaeosortase C in four others.

22 , optimization of ion pair concentration and PEF parameters caused a 1.5 or 2-fold increase of magnes

23 second-highest FVC (dFVC), FEV1 (dFEV1), and PEF (dPEF), from prebronchodilator spirometry, and anthr

24 ciation was found between ozone exposure and PEF.

25 significant circadian variations in FEVC and PEF.

26 force components (K-fibre, spring force and PEF) acting on individual sister kinetochores in vivo.

27 e limits for repeatability of FEV1, FVC, and PEF during spirometry test sessions in adult outpatients

28 microbial safety, the impact of heat, HP and PEF pasteurisation on the volatile profile of orange jui

29 ntly, pulsed electric technologies (HVED and PEF) show good prospects for enhanced bioaccessibility o

30 Pre-incubation with J. oxycedrus badia PEF for 24h protected neurons from injury in the neurode

31 ant effect on PEF (L/min), weekly home-based PEF, FVC, and FEV1.

32 's peel into juice was maximally achieved by PEF.

33 treatment differences for HF (overall and by PEF and REF).

34 Furthermore, olive oil obtained by PEF showed total phenolic content, total phytosterols an

35 contents of flavonols in musts pretreated by PEF and TV were significantly higher comparing to the co

36 , kt-MT attachment stability is modulated by PEFs, which can be generated by distinct force-producing

37 (NOD/SCID)/beta2m-/- mice was unperturbed by PEFs.

38 Here, we describe a live-cell PEF assay in which tension was applied to chromosomes by

39 ) TACE procedures resulted in complications [PEF 28 (25.2%), NV 4 (3.6%), abdominal pain 9 (8.1%), in

40 Consequently, PEF processing was very effective for the inactivation o

41 d risk estimates still depend on contentious PEFs and cancer slope factors.

42 Efficacy was assessed using FEV1, daily PEF, and an asthma control score.

43 detrended fluctuation analysis to once-daily PEF data from 493 participants in the LOCCS (Leukotriene

44 For this purpose, four different PEF treatments were applied using a continuous system ov

45 ients hospitalized for HF with preserved EF (PEF) or reduced EF (REF).

46 rve [AUC] 445 vs -82.5, p=0.005) and evening PEF (median AUC 548 vs -85, p=0.014).

47 n most secondary outcomes, including evening PEF, with a difference of 35.3 liters per minute (P<0.00

48 9.9 +/- 6.7 vs. 34.2 +/- 4.7 L/min), evening PEF (69.9 +/- 5.8 vs. 31.1 +/- 4.5 L/min), the percentag

49 udies of asthma therapy-morning PEF, evening PEF, asthma symptom scores, rescue albuterol sulfate use

50 one was the only exposure related to evening PEF with 5-d cumulative lag exposure showing the greates

51 For 257 (7.3%) exacerbations, PEF did not recover within 99 days.

52 Potency equivalency factors (PEFs) developed by the California Environmental Protecti

53 el that employs potency equivalency factors (PEFs) for targeted carcinogenic PAHs.

54 at peak expiratory flow (FEV(PEF)), and FEV(PEF)/FVC% were significantly lower in newborns exposed t

55 piratory volume at peak expiratory flow (FEV(PEF)), and FEV(PEF)/FVC% were significantly lower in new

56 Measurements of FEV(1), FEVC, PEF, blood cortisol, and core body temperature (CBT) wer

57 -TACE complications: postembolization fever (PEF), nausea and vomiting (NV), abdominal pain, infectio

58 PS1-deficient primary embryonic fibroblasts (PEFs).

59 cells to an external pulsed electric field (PEF) increases the natural potential difference across t

60 igh pressure (HP) and pulsed electric field (PEF) processing for mild pasteurisation of orange juice.

61 Effects of pulsed electric field (PEF) processing on 28 aroma active compounds, and four p

62 o study the effect of pulsed electric field (PEF) processing on the bioprotective capacity of carrot

63 er being treated with pulsed electric field (PEF) processing.

64 impact of the use of pulsed electric field (PEF) technology on Arroniz olive oil production in terms

65 studies the effect of pulsed electric field (PEF) treatment at moderate and high field strengths (E=0

66 The influence of pulsed electric field (PEF) treatment on the anthocyanin extraction yield (AEY)

67 ere to investigate if pulsed electric field (PEF) treatments caused cellular/structural alterations i

68 and whey proteins) in pulsed electric field (PEF)-treated milk were compared with thermally treated m

69 rees C for 10min) or pulsed electric fields (PEF) (1.4-1.8kV/cm, 260-690kJ/kg) treatments on the in v

70 es processed by both pulsed electric fields (PEF) and heat pasteurization (HP) was evaluated in the s

71 g of orange juice by pulsed electric fields (PEF) and thermal pasteurisation was carried out to compa

72 Pulsed electric fields (PEF) and ultrasound (US) are promising innovative techno

73 The impact of pulsed electric fields (PEF) for a non-thermal disintegration on the important j

74 nalyze the effect of pulsed electric fields (PEF) in mass transfer as a pre-treatment of the OD using

75 ae were treated with pulsed electric fields (PEF) in order to obtain a maximum accumulation of seleni

76 The effect of pulsed electric fields (PEF) on the carotenoid content of tomato juices was stud

77 study the effect of pulsed electric fields (PEF) on the stilbene content of three grape varieties.

78 ceration times after pulsed electric fields (PEF) using 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical

79 mixture processed by pulsed electric fields (PEF), high voltage electrical discharges (HVED) and ultr

80 oietic cells through pulsed electric fields (PEFs) effectively purges myeloma cells without sacrifici

81 eatments techniques: pulsed electric fields (PEFs), enzymes treatment (ET) and thermovinification (TV

82 m exposure to 40 mus pulsed electric fields (PEFs).

83 e reveal a role for the parietal eye fields (PEFs) in directing spatially selective processes relatin

84 sed electric energy (pulsed electric fields, PEF or high voltage electrical discharges, HVED) of nutr

85 tent of total phenolics and total flavonols, PEF and TV were statistically different, but ET was not

86 7 +/- 0.03 L), morning peak expiratory flow (PEF) (89.9 +/- 6.7 vs. 34.2 +/- 4.7 L/min), evening PEF

87 The difference in peak expiratory flow (PEF) (DeltaPEF, l/min) after 16 weeks of treatment with

88 ine if fluctuations in peak expiratory flow (PEF) are predictive of subsequent treatment failure and

89 endpoint was change in peak expiratory flow (PEF) as percentage predicted (PEF%p) from baseline to we

90 ed morning and evening peak expiratory flow (PEF) at home.

91 thors examined whether peak expiratory flow (PEF) is a valid measure of health status in older adults

92 0.57), or twice daily peak expiratory flow (PEF) measurements (mean difference in morning PEF 1.18 L

93 f both spirometers and peak expiratory flow (PEF) meters, but for certain flow profiles the input sig

94 QLQ (primary outcome), peak expiratory flow (PEF) monitoring, diurnal peak flow variability (dPFV, an

95 on and daily change in peak expiratory flow (PEF) was studied in a sample of 473 nonsmoking women (ag

96 set of questions plus peak expiratory flow (PEF) with optimal sensitivity (SN) and specificity (SP).

97 d points FEV1, morning peak expiratory flow (PEF), and asthma control days (ACDs).

98 ratory-tract symptoms, peak expiratory flow (PEF), and measured personal NO2 exposures every week for

99 spiratory symptoms and peak expiratory flow (PEF), and when stable underwent spirometry every 3 month

100 hodilator FVC, FEV(1), peak expiratory flow (PEF), forced midexpiratory flow (FEF(50)), and skin pric

101 rs, who recorded daily peak expiratory flow (PEF), respiratory symptoms, medication, medical consulta

102 measuring the morning peak expiratory flow (PEF), with a mean difference of 25.8 liters per minute (

103 y endpoint was morning peak expiratory flow (PEF).

104 ry outcome was morning peak expiratory flow (PEF).

105 51.4 L/min lower A.M. peak expiratory flow (PEF; p = 0.005) in B16Arg/Arg subjects(salmeterol, n = 1

106 age) were observed in grape juices following PEF treatment.

107 for FEV(1)/FEVC in 5 of 10 subjects and for PEF in 6 of 10 subjects.

108 ly 13.3 kV/cm and approximately 40 kV/cm for PEF and HVED treatments were used, respectively.

109 al test p=0.51), although the difference for PEF decreases of more than 30% approached significance (

110 R = 3.603) were independent risk factors for PEF.

111 This was also observed for PEF treated samples at an energy input of 256kJ/kg (37.0

112 an increase by 18% and 32% respectively for PEF and TV, and only 3% for ET comparing to the control.

113 d as the principal force-producing agent for PEFs.

114 e kinesin-10-dependent polar ejection force (PEF).

115 s, which combine with polar ejection forces (PEF) and elastic inter-sister chromatin to govern chromo

116 Furthermore, polar ejection forces (PEFs), highest near poles, can stabilize improper attach

117 During mitosis, "polar ejection forces" (PEFs) are hypothesized to direct prometaphase chromosome

118 reduced left ventricular ejection fraction (PEF [>or=50%] or REF [<50%]).

119 irst time, a (poly)phenol-enriched fraction (PEF) from leaves of Corema album, and used in vitro and

120 trachomatis, the population excess fraction (PEF), can be estimated from serological data using finit

121 ne (TEF) and polyphenols enriched fractions (PEF) prepared from tea dust were tested in a model syste

122 ly characterize phenolic-enriched fractions (PEFs) from four wild Juniperus sp. found in Portugal (Ju

123 -group-specific population excess fractions (PEFs) of PID due to C. trachomatis, using routine data,

124 e freshly fermented model wine obtained from PEF and TV pretreated musts being the most different wit

125 ynthesis of polyethylene furandicarboxylate (PEF), which is a potential large-scale substitute for pe

126 Furthermore, PEF treatment was able to selectively purge blood prepar

127 Forty-six percent of Hispanics had PEF (EF >40%), whereas 54% had REF (EF <40%); 55% and 45

128 40%); 55% and 45% of non-Hispanic whites had PEF and REF, respectively.

129 n echocardiograms: HF-REF if EF was <50%, HF-PEF if EF was consistently >/=50%, and HF-Recovered if E

130 and creatinine were greater in HF-REF and HF-PEF patients.

131 For both HF-REF and HF-PEF, there were few regional differences in rates of all

132 e and event-free survival than HF-REF and HF-PEF.

133 outcomes by level of CKD, separately for HF-PEF and HF with reduced left ventricular EF.

134 Current therapeutic recommendations for HF-PEF are aimed mostly at symptomatic management and treat

135 ied by geographic region, and more so for HF-PEF than for HF-REF.

136 failure with preserved ejection fraction (HF-PEF) occurs in approximately 50% of patients with heart

137 failure with preserved ejection fraction (HF-PEF) on patients' lives and the effects of irbesartan.

138 r those with preserved ejection fraction (HF-PEF).

139 with HF with preserved ejection fraction (HF-PEF).

140 erved left ventricular ejection fraction (HF-PEF).

141 with HF with preserved ejection fraction [HF-PEF]; mean age, 68 years; deaths per 1000 patient-years,

142 mining other novel therapeutic targets in HF-PEF are keenly awaited.

143 e randomized clinical trials completed in HF-PEF patients did not achieve statistical significance in

144 idence interval, 1.5-2.7; P<0.001) and in HF-PEF patients was 1.3 (95% confidence interval, 0.90-2.0;

145 idence interval, 2.4-6.8; P<0.001) and in HF-PEF patients was 2.3 (95% confidence interval, 1.2-4.5;

146 ely related to outcomes in HF-REF than in HF-PEF.

147 of all-cause mortality in HF-REF than in HF-PEF.

148 ical record data were used to divide into HF-PEF and reduced left ventricular EF on the basis of quan

149 and ongoing research in the treatment of HF-PEF is reviewed in this article.

150 ensitive measure of the adverse impact of HF-PEF on patients' lives.

151 r more of the definition and diagnosis of HF-PEF, the risk profile of patients enrolled, and the thre

152 Patients with symptomatic HF-PEF were randomly assigned to irbesartan (up to 300 mg d

153 ne MLHFQ scores of 43+/-21 indicated that HF-PEF had a substantial adverse effects.

154 We identified 14 579 patients with HF-PEF and 9762 with HF with reduced left ventricular EF.

155 Rates in patients with HF-PEF were highest in the United States/Canada (HF hospita

156 For example, among patients with HF-PEF, the risk of death was nearly double for eGFR 15 to

157 emonstrated specifically in patients with HF-PEF.

158 strategies specifically for patients with HF-PEF.

159 nd toward improvement among patients with HF-PEF.

160 improved within the study period (Hispanics PEF: 75.2-95.1%; non-Hispanic whites PEF: 79.0-92.7%; Hi

161 singly weak and erratic, but it explains how PEFs can guide chromosome movements without severely def

162 ed the unevenness of the PEF effect, however PEF caused no changes in overall tuber/tissue structure.

163 following intestinal digestion, while HVED, PEF and USN treatments increased total carotenoid bioacc

164 tions in Oxalis tuberosa (oca) tubers and if PEF treatment could reduce tuber oxalate levels.

165 However, it is not known if PEF orders of magnitude shorter than the activation time

166 least 20% difference in the yearly change in PEF%p, measured with hospital-based and weekly home-base

167 ominantly by change in symptoms or change in PEF, but the pattern was not affected by the dose of inh

168 We looked at change in PEF, symptoms, and use of rescue beta-agonists during th

169 ed with more symptoms and smaller changes in PEF than those identified on the basis of PEF criteria.

170 thin 72 h of injection (defined as a fall in PEF of >20%).

171 ants with paired data, 11 recorded a fall in PEF of more than 20% after vaccine compared with three a

172 ions were characterized by a gradual fall in PEF over several days, followed by more rapid changes ov

173 ebenone significantly attenuated the fall in PEF%p from baseline to week 52 in the mITT (-3.05%p [95%

174 The improvement in PEF did not differ between genotypes (difference [Arg/Ar

175 Quantification of the increase in PEF energy to ensure a ten-fold reduction in De (ze, 63.

176 onsecutive symptom-free days and recovery in PEF as return to preexacerbation levels.

177 syncytial virus [p=0.01]) and a reduction in PEF of more than 12 L/min for picornavirus (p=0.04) for

178 entary aqueous extraction (+SE) that include PEF-assisted extraction as the first step, and +SE at 50

179 profiles when compared with the pump's input PEF, but this would be true for only one profile when co

180 signed for exposing cell cultures to intense PEFs while carrying out real-time microscopy.

181 ated by heat treatments or by high-intensity PEF (HIPEF) and stored under refrigeration for 56 days.

182 First, moderate-intensity PEF (MIPEF) was applied to raw tomatoes.

183 Compared to untreated grape juice, PEF pre-treatment on grapes enhanced the release of the

184 Low PEF (<80% of predicted value) was prevalent among person

185 e of health status in older persons, and low PEF is an independent predictor of hospitalization and p

186 models and to examine relations between low PEF values and other clinical factors.

187 tantially higher adjusted odds of having low PEF, on par with those for conditions known to be associ

188 Persons with low PEF in 2006 were more likely to be hospitalized (OR = 1.

189 nd ICS concurrently (n = 8) had a lower A.M. PEF (36.8 L/min difference, p = 0.048) than B16Gly/Gly s

190 values) were A.M.FEF25-75, A.M.FEV1, and A.M.PEF, (s/b = 0.46, 0.48, and 0.59).

191 ily time-activity-symptom diary and measured PEF (peak expiratory flow) using peak flow meters.

192 gression model for difficulty with mobility, PEF remained an independent factor (odds ratio (OR) = 1.

193 Morning PEF decrements were significantly associated with H+ and

194 significantly increased (p < 0.001) morning PEF at endpoint (53.5 L/min) as compared with placebo (-

195 ence intervals, 43, 231; p = 0.019), morning PEF L/m (mean difference, 36.8; 95% confidence intervals

196 08; 95% CI, 2.00-8.31; P < .001) and morning PEF (odds ratio, 2.12; 95% CI, 1.12-4.01; P = 0.021), as

197 tments produced similar increases in morning PEF (7.1 to 8.3 percent; approximately 32 liters per min

198 from placebo recipients in change in morning PEF (median area under curve [AUC] 445 vs -82.5, p=0.005

199 EF) measurements (mean difference in morning PEF 1.18 L/min; -14.29 to 17.14), and mean difference in

200 The primary endpoint, change in morning PEF at Days 50-56 compared with the last 7 d of the run-

201 steroids (n = 311) or a reduction in morning PEF of > 30% on two consecutive days.

202 We did not observe changes in morning PEF, FEV1, and PD20 in any of the three groups nor betwe

203 .73 (95% CI = 0.07 to 1.38) L/min in morning PEF, respectively.

204 After 18 weeks of treatment, mean morning PEF in Arg/Arg participants was 21.4 L/min (95% CI 11.8-

205 almeterol and tiotropium in terms of morning PEF (n = 90 and 78, respectively) and ACDs (n = 49 and 5

206 In Gly/Gly participants, morning PEF was 21.5 L/min (11.0-32.1) higher when participants

207 f clinical studies of asthma therapy-morning PEF, evening PEF, asthma symptom scores, rescue albutero

208 significant improvement in morning and night PEF (mean difference, 29.1; CI, 2.3, 56; p = 0.04 and 52

209 Hz or 100 Hz for 1 min) alternately by 12-ns PEF and by conventional pulses.

210 eripheral nerve can be accomplished by 12-ns PEF without electroporation.

211 The PME activity of PEF-processed samples decreased or did not change, while

212 th a dose-response effect, while addition of PEF in bread produced a significant decrease (p<0.05).

213 Application of PEF caused the increase of ions accumulation by 65% for

214 The application of PEF using moderate strengths at different times during c

215 in PEF than those identified on the basis of PEF criteria.

216 nowledge that demonstrates the capability of PEF technology to produce plant-based foods with better

217 ty associated with aroma active compounds of PEF-treated peach nectar.

218 rum samples in each, from which estimates of PEF were derived.

219 of consistency between adjusted estimates of PEF, but all have wide 95% CrIs.

220 nt, the present study assessed the impact of PEF and US treatments, applied individually and in combi

221 In addition, the influence of PEF on their physicochemical composition was studied.

222 Optimization of PEF parameters led to the further rise in the both ions

223 The presence of PEF and TEF inhibited formation of fluorescent advanced

224 xponent alpha, reflecting self-similarity of PEF, in relation to treatment failure from the run-in pe

225 The use of PEF had no negative effects on general chemical and sens

226 We evaluated the coefficient of variation of PEF (CVpef) and the scaling exponent alpha, reflecting s

227 with a decrease in mean diurnal variation of PEF at Week 8 (p = 0.02; 95% confidence interval [CI], -

228 nase (AAK) opposes the stabilizing effect of PEFs.

229 However, the exact role of PEFs is unclear, because little is known about their mag

230 Based on PEF data from our previous studies of a similar patient

231 Idebenone also had a significant effect on PEF (L/min), weekly home-based PEF, FVC, and FEV1.

232 At optimal PEF parameters: electric field strength of 3kV/cm and pu

233 ce methodology was used to determine optimal PEF treatment and optimise anthocyanin extraction.

234 , compared to either 60 degrees C heating or PEF processing.

235 profile when compared with the pump's output PEF as predicted by the model.

236 The CAPTURE plus PEF exhibited improved SN and SP for all cases versus al

237 concentrations of two different pollutants (PEF decrements related to PM2.5 in morning and O3 in eve

238 Mean %pred FEV(1) was 87.4, mean %pred PEF was 85.1; 41% reported respiratory symptoms every we

239 and low serum albumin (p = 0.035) predicted PEF while low serum albumin (p = 0.021) and low platelet

240 ted in 1992), were used to develop predicted PEF regression models and to examine relations between l

241 tes, tumour size and female gender predicted PEF post-TACE.

242 piratory flow (PEF) as percentage predicted (PEF%p) from baseline to week 52, measured with spirometr

243 The application of two-stage procedure PEF+supplementary aqueous extraction (+SE) that include

244 d motility or tip-tracking activity produced PEFs.

245 In this sense, PEF pre-treatments were done using three different volta

246 Equivalent estimates based on the standard PEF formula from case-control studies were 0% and over 6

247 Despite the retention of starch, PEF treatment reduced tuber oxalate contents by almost 5

248 roughout the metaphase plate, with a steeper PEF potential well towards the periphery and a concomita

249 by a macromolecular cytosolic factor, termed PEF (permeability enhancing factor).

250 of these physical methods demonstrated that PEF redistributed a greater proportion of intracellular

251 We hypothesize that PEF activity could help determine whether cells can reco

252 These results indicate that PEF could be a suitable technology for obtaining musts w

253 It is obvious that PEF treatment affects the temperature stability of endog

254 This study clearly shows that PEF could add value to carrots by maximising bioprotecti

255 The PEF (males, <350 L/min; females, <250 L/min) SN and SP w

256 The PEF decreases from 53.5% (95% CrI, 15.6%-100%) in women

257 The PEF treatment time of 131 mus on average led consistentl

258 The PEF-treated samples had higher sensory scores than the h

259 Additionally, the PEF-determined BaP-equivalent concentrations were compar

260 The PME inactivation level after the PEF (25.26 kV/cm-1206.2 mus) and HP (90 degrees C-20s) t

261 the orange juice samples enhanced after the PEF or thermal pasteurisation.

262 genicity was less than dose-additive and the PEF-method provided higher estimates of BaP-equivalents

263 as generally more than dose-additive and the PEF-method provided lower estimates of BaP-equivalents t

264 rly show that the best time for applying the PEF-treatment through the red fermentation is during the

265 00 g fw) was similar to that obtained in the PEF-treated sample using water (65.8 mg/100 g fw).

266 Interestingly, the PEF promoted the formation of non-toxic alphaSyn species

267 bility tests confirmed the unevenness of the PEF effect, however PEF caused no changes in overall tub

268 essing PME inactivation as a function of the PEF treatment conditions, and this enabled the estimatio

269 y properties were found as a function of the PEF treatment times.

270 Minimum and maximum estimates of the PEF were 28.0% (95% credible interval: 6.9, 50.0) and 46

271 The PEFs obtained were rich sources of phenolic compounds, e

272 The PEFs of PID due to C. trachomatis decline steeply with a

273 directly measure the speed and force of the PEFs developed on chromosome arms.

274 Therefore, PEF could be an appropriate technology to improve olive

275 Therefore, PEF was possible with water, a more environmental-friend

276 This PEF treatment increased the AEY, the effect being higher

277 Flowing cells through PEFs is a promising technology for rapid tumor cell purg

278 ipheral blood (PB) cells were passed through PEFs at 1.35 kV/cm to 1.4 kV/cm, resulting in 3- to 4-lo

279 of intracellular water migration compared to PEF.

280 15 min exposure of the 20 h grown culture to PEF of 5.0 kV/cm and 20 mus pulse width, accumulation of

281 ion of AAO released after being subjected to PEF treatment.

282 A parietal area close to PEFs appears to be specialized for processing the future

283 Mobilized peripheral blood exposed to PEFs was enriched for CD34+/CD38- cells and stem cell fu

284 eripheral blood mononuclear cells (PBMCs) to PEFs caused stepwise elimination of monocytes without af

285 Subjects took PEF measurements twice daily for a 2-wk period using a s

286 dge of the molecular mechanisms underpinning PEF generation is incomplete.

287 erties of the tuber tissues led to an uneven PEF effect with the tuber inner cores softening more tha

288 Various PEF treatments using electric field strength between 0.2

289 When PEF was combined with US at low temperatures the differe

290 inetochore-MT attachments are weakened where PEFs are most likely to strengthen them.

291 spanics PEF: 75.2-95.1%; non-Hispanic whites PEF: 79.0-92.7%; Hispanics REF: 67.7-88.4%; non-Hispanic

292 CAPTURE with PEF can identify patients with COPD who would benefit fr

293 ality risk was observed among Hispanics with PEF (odds ratio, 0.50; 95% confidence interval, 0.31-0.8

294 ative to non-Hispanic whites, Hispanics with PEF or REF were more likely to be younger and to have di

295 Hispanic HF patients with PEF had better in-hospital survival than non-Hispanic wh

296 Whole oca tubers were treated with PEF at different electric field strengths up to 1.2kV/cm

297 The samples treated with PEF had more stable flavonoids and phenolic acids than t

298 f Saccharomyces cerevisiae were treated with PEF to improve simultaneous accumulation of magnesium an

299 control as well as in the cells treated with PEF.

300 gd.m. for zinc, in the cultures treated with PEF.

301 pital survival than non-Hispanic whites with PEF.